Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12367168 | 0.87 | PTGS2 (0.35) | CA1CA2KMT2A | |
| SCHEMBL10000757 | 0.80 | FASN (0.32) | — | |
| SCHEMBL10000754 | 0.73 | AKR1B1 (0.36) | CA2KMT2A | |
| SCHEMBL10000756 | 0.73 | PTGS2 (0.37) | KMT2A | |
| SCHEMBL12744505 | 0.65 | ERBB2 (0.40) | — | |
| SCHEMBL7624172 | 0.64 | KMT2A (0.37) | KMT2A | |
| SCHEMBL4577529 | 0.64 | KMT2A (0.38) | KMT2A | |
| SCHEMBL20899705 | 0.64 | KMT2A (0.38) | KMT2A | |
| SCHEMBL16597206 | 0.63 | ERBB2 (0.39) | — | |
| SCHEMBL14902212 | 0.63 | KMT2A (0.35) | KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8207229-B1 | Preparation of hydroquinone amide compounds with antioxidant properties | CATALYS SAS (FR) | 2012-06-26 | — | — | US | disclosed |
| US-8003824-B2 | Preparation of hydroquinone amide compounds with antioxidant properties | CATALYS SAS (FR) | 2011-08-23 | — | — | US | disclosed |
| US-20110021820-A1 | Preparation of Hydroquinone Amide Compounds with Antioxidant Properties | CATALYS SAS (FR) | 2011-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110021820-A1 | Preparation of Hydroquinone Amide Compounds with Antioxidant Properties | NQO1, TYR, AHR | CA1 4210/4885CA2 3237/4885KMT2A 1182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.